Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60.4M Sell
3,172,009
-148,150
-4% -$2.86M 0.92% 24
2025
Q4
$54.4M Buy
3,320,159
+1,287,282
+63% +$22.7M 0.77% 34
2025
Q3
$38.2M Buy
+2,032,877
New +$36.5M 0.59% 37
2024
Q4
Sell
-510,764
Closed -$9.16M 170
2024
Q3
$9.16M Buy
+510,764
New +$9.31M 0.15% 73
2023
Q1
Sell
-120,289
Closed -$1.85M 321
2022
Q4
$1.85M Hold
120,289
0.02% 279
2022
Q3
$2.29M Sell
120,289
-9,872
-8% -$196K 0.03% 264
2022
Q2
$2.34M Hold
130,161
0.03% 247
2022
Q1
$3.92M Sell
130,161
-31,638
-20% -$987K 0.04% 172
2021
Q4
$4.65M Buy
+161,799
New +$5.27M 0.05% 139

Other funds holding XP

Oaktree Capital Management's XP Position: Q1 2026 in Review

Oaktree Capital Management reduced its XP (XP) stake by 4.5% in Q1 2026, selling an estimated $2.86M and leaving 3,172,009 shares worth $60.4M. The position accounts for 0.92% of the portfolio, ranked #24.

Oaktree Capital Management first reported a position in XP in Q4 2021 and has held it in 9 quarters since. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • Oaktree Capital Management held 3,172,009 shares of XP worth $60.4M as of Q1 2026.
  • Oaktree Capital Management sold 148,150 XP shares in Q1 2026, an estimated $2.86M.
  • XP made up 0.92% of Oaktree Capital Management's portfolio in Q1 2026, its #24 holding.
  • Oaktree Capital Management first reported a position in XP in Q4 2021 and has held it in 9 quarters since.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on Oaktree Capital Management's 13F filing for Q1 2026, filed 15 May 2026.